The Alliance for Regenerative Medicine Announces the Appointment of Timothy D. Hunt as Chief Executive Officer
August 11, 2022 02:00 ET
|
The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine Announces the Appointment of Timothy D. Hunt as Chief Executive Officer WASHINGTON, D.C. – August 10, 2022 The Alliance for Regenerative Medicine (ARM), the...
Alliance for Regenerative Medicine Announces CEO Transition
April 27, 2022 09:07 ET
|
The Alliance for Regenerative Medicine
CEO to step down after leading ARM through period of tremendous growth; Alliance for Regenerative Medicine Announces CEO Transition New Officer Roles Announced WASHINGTON, DC – April 27, 2022 ...
Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicine
August 18, 2021 09:00 ET
|
The Alliance for Regenerative Medicine
GLOBAL CELL & GENE THERAPY SECTOR ON PACE FOR ANNUAL RECORDS IN PRODUCT APPROVALS AND FINANCINGS, SAYS ALLIANCE FOR REGENERATIVE MEDICINE ARM’s H1 2021 Report Chronicles ‘A Year of Firsts’ For...
German Parliament Approves Legislation to Accelerate Access to Life-Changing Cell and Gene Therapies
June 15, 2021 01:00 ET
|
The Alliance for Regenerative Medicine
GERMAN PARLIAMENT APPROVES LEGISLATION TO ACCELERATE ACCESS TO LIFE-CHANGING CELL AND GENE THERAPIES The Alliance for Regenerative Medicine advocated for reducing the “NUB gap” for advanced...
ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation
May 25, 2021 08:54 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO...
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
March 24, 2021 11:28 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients Stand To Benefit From Early Focus On Life-Changing ATMPs BRUSSELS, BELGIUM...
Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020
March 16, 2021 10:08 ET
|
The Alliance for Regenerative Medicine
ALLIANCE FOR REGENERATIVE MEDICINE ANNUAL REPORT HIGHLIGHTS RECORD SECTOR GROWTH AND RESILIENCE IN 2020 Sector financing reached $19.9B in 2020, doubling from the previous year; 2021 is...
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
February 03, 2021 09:00 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients BRUSSELS, BELGIUM –...
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
November 19, 2020 09:36 ET
|
The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020 Washington, DC – November 19, 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
July 29, 2020 02:00 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies BRUSSELS, BELGIUM. – July...